![Corey Fishman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Corey Fishman
Chief Executive Officer at
Iterum Pharmaceuticals LLC
Net worth: 4 112 $ as of 31/03/2026
Profile
Corey N.
Fishman was the founder of Iterum Therapeutics Plc, founded in 2015, where the titles held included President, Chief Executive Officer & Director.
Current jobs include Chief Executive Officer at Iterum Pharmaceuticals LLC, Chief Executive Officer at Iterum Therapeutics US Ltd., Director at Iterum Therapeutics International Ltd., and Director at Iterum Therapeutics US Holding Ltd. Former jobs include Independent Director at BioSpecifics Technologies Corp.
in 2020, Independent Director at Momenta Pharmaceuticals, Inc. from 2016 to 2020, Chief Financial Officer at MedPointe, Inc. from 2002 to 2008, Chief Financial Officer at MedPointe Healthcare, Inc. from 2006 to 2008, Principal at Lyphomed, Inc., Chief Financial Officer at GANIC Pharmaceuticals, Inc. from 2008 to 2010, Chief Financial Officer at Meda Pharmaceuticals, Inc., and Treasurer, Chief Operating & Financial Officer at Durata Therapeutics, Inc. from 2014 to 2015.
Education includes graduate studies at Purdue University and undergraduate studies at the University of Illinois At Urbana–Champaign.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/11/2025 | 137,062 ( 0.26% ) | 4 112 $ | 31/03/2026 |
Corey Fishman active positions
| Companies | Position | Start |
|---|---|---|
Iterum Pharmaceuticals LLC
 Iterum Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Executive Officer | - |
Iterum Therapeutics International Ltd.
 Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Develops clinical-stage pharmaceutical products | Director/Board Member | - |
Iterum Therapeutics US Holding Ltd.
 Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Director/Board Member | - |
Iterum Therapeutics US Ltd.
 Iterum Therapeutics US Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Chief Executive Officer | - |
Former positions of Corey Fishman
| Companies | Position | End |
|---|---|---|
| ITERUM THERAPEUTICS PLC | Founder | 27/03/2026 |
| BIOSPECIFICS TECHNOLOGIES CORP. | Director/Board Member | 02/12/2020 |
| MOMENTA PHARMACEUTICALS, INC. | Director/Board Member | 23/06/2020 |
| DURATA THERAPEUTICS INC | Director of Finance/CFO | 01/02/2015 |
GANIC Pharmaceuticals, Inc.
 GANIC Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops and markets pharmaceutical products | Director of Finance/CFO | - |
Training of Corey Fishman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
43
1st degree connections
15
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 15 |
|---|---|
BioSpecifics Technologies Corp.
 BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology Develops injectable collagenase clostridium histolyticum (CCH) for multiple indications | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
MedPointe, Inc.
 MedPointe, Inc. Pharmaceuticals: MajorHealth Technology Develops, markets, and sells therapeutics | Health Technology |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedPointe Healthcare, Inc.
 MedPointe Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug manufacturing company | Health Technology |
Lyphomed, Inc.
 Lyphomed, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets injectable drugs | Health Technology |
GANIC Pharmaceuticals, Inc.
GANIC Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops and markets pharmaceutical products | Retail Trade |
Meda Pharmaceuticals, Inc.
 Meda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops drugs and pharmaceuticals | Health Technology |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
Iterum Pharmaceuticals LLC
Iterum Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Iterum Therapeutics Plc
 Iterum Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which engages in the development and commercialization of sulopenem | Health Technology |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iterum Therapeutics US Ltd.
Iterum Therapeutics US Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Iterum Therapeutics International Ltd.
Iterum Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Develops clinical-stage pharmaceutical products | Health Technology |
Iterum Therapeutics US Holding Ltd.
Iterum Therapeutics US Holding Ltd. Financial ConglomeratesFinance Functions as an investment holding company | Finance |
- Stock Market
- Insiders
- Corey Fishman
Choose MarketScreener 
